Structure-based development of PDEδ inhibitors
Abstract: The prenyl binding protein PDEδ enhances the diffusion of farnesylated Ras proteins in the cytosol, ultimately affecting their correct localization and signaling. This has turned PDEδ into a promising target to prevent oncogenic KRas signaling. In this review we summarize and describe the structure-guided-development of the three different PDEδ inhibitor chemotypes that have been documented so far. We also compare both their potency for binding to the PDEδ pocket and their in vivo efficiency in suppressing oncogenic KRas signaling, as a result of the inhibition of the PDEδ/KRas interaction.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Structure-based development of PDEδ inhibitors ; volume:398 ; number:5-6 ; year:2017 ; pages:535-545 ; extent:11
Biological chemistry ; 398, Heft 5-6 (2017), 535-545 (gesamt 11)
- Urheber
- DOI
-
10.1515/hsz-2016-0272
- URN
-
urn:nbn:de:101:1-2408051816433.818360231998
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martín-Gago, Pablo
- Fansa, Eyad Kalawy
- Wittinghofer, Alfred
- Waldmann, Herbert
Ähnliche Objekte (12)
Structure-based design of hyaluronidase inhibitors
Structure-based development of secondary amines as aspartic protease inhibitors
Structure-Based Search for New Inhibitors of Cholinesterases
Structure-based inhibitor design for the antimalarial target plasmepsin
Structure-based design and synthesis of novel CLK1 inhibitors
In silico structure-based approaches to design Mdmx inhibitors
Structure-based design of selective salt-inducible kinase (SIK) inhibitors
Structure‐based screening of tetrazolylhydrazide inhibitors versus KDM4 histone demethylases
Structure‐Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases
Manganese oxalates - structure-based Insights
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Identification of Plk1 type II inhibitors by structure-based virtual screening
Structure-based design of hyaluronidase inhibitors
Structure-based development of secondary amines as aspartic protease inhibitors
Structure-Based Search for New Inhibitors of Cholinesterases
Structure-based inhibitor design for the antimalarial target plasmepsin
Structure-based design and synthesis of novel CLK1 inhibitors
In silico structure-based approaches to design Mdmx inhibitors
Structure-based design of selective salt-inducible kinase (SIK) inhibitors
Structure‐based screening of tetrazolylhydrazide inhibitors versus KDM4 histone demethylases
Structure‐Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases
Manganese oxalates - structure-based Insights
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Identification of Plk1 type II inhibitors by structure-based virtual screening
Structure-based design of hyaluronidase inhibitors
Structure-based development of secondary amines as aspartic protease inhibitors
Structure-Based Search for New Inhibitors of Cholinesterases
Structure-based inhibitor design for the antimalarial target plasmepsin
Structure-based design and synthesis of novel CLK1 inhibitors
In silico structure-based approaches to design Mdmx inhibitors
Structure-based design of selective salt-inducible kinase (SIK) inhibitors
Structure‐based screening of tetrazolylhydrazide inhibitors versus KDM4 histone demethylases
Structure‐Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases
Manganese oxalates - structure-based Insights
Structure-Based Development of Selective Orexin 1 Receptor Antagonists